HBV-IN-33

• UNSPSC Description:

  HBV-IN-33 (C-49), a HBV inhibitor, notably suppresses HBV replication in HepAD38, HepG2-HBV1.3 and HepG2-NTCP cells[1].

• Target Antigen:

  HBV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/hbv-in-33.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=C(C)N(CC(F)(F)F)C(C)=C1S(=O)(N2CCC[C@@H](C2)C(NC3=CC=C(C(C)=C3)F)=O)=O)OCC

• Molecular Weight:

  547.56

• References & Citations:

  [1]Jiaxin Yin, et al. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice. Eur J Med Chem. 2023 Mar 5;249:115141.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported